Cansino Biologics Inc - Asset Resilience Ratio

Latest as of December 2025: 19.62%

Cansino Biologics Inc (688185) has an Asset Resilience Ratio of 19.62% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 688185 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.41 Billion

≈ $206.10 Million USD Cash + Short-term Investments

Total Assets

CN¥7.18 Billion

≈ $1.05 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Cansino Biologics Inc's Asset Resilience Ratio has changed over time. See 688185 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Cansino Biologics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688185 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.41 Billion	19.62%
Total Liquid Assets	CN¥1.41 Billion	19.62%

Asset Resilience Insights

Good Liquidity Position: Cansino Biologics Inc maintains a healthy 19.62% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Cansino Biologics Inc Industry Peers by Asset Resilience Ratio

Compare Cansino Biologics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Cansino Biologics Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Cansino Biologics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.62%	CN¥1.41 Billion ≈ $206.10 Million	CN¥7.18 Billion ≈ $1.05 Billion	-0.96pp
2024-12-31	20.58%	CN¥1.64 Billion ≈ $239.84 Million	CN¥7.96 Billion ≈ $1.17 Billion	-1.66pp
2023-12-31	22.25%	CN¥2.07 Billion ≈ $303.34 Million	CN¥9.32 Billion ≈ $1.36 Billion	-0.01pp
2022-12-31	22.25%	CN¥2.55 Billion ≈ $373.43 Million	CN¥11.47 Billion ≈ $1.68 Billion	+2.66pp
2021-12-31	19.59%	CN¥2.33 Billion ≈ $340.37 Million	CN¥11.87 Billion ≈ $1.74 Billion	+9.71pp
2020-12-31	9.88%	CN¥666.64 Million ≈ $97.55 Million	CN¥6.75 Billion ≈ $987.46 Million	-21.07pp
2019-12-31	30.95%	CN¥552.34 Million ≈ $80.83 Million	CN¥1.78 Billion ≈ $261.13 Million	+13.36pp
2018-12-31	17.59%	CN¥140.00 Million ≈ $20.49 Million	CN¥795.88 Million ≈ $116.46 Million	-28.88pp
2017-12-31	46.47%	CN¥402.64 Million ≈ $58.92 Million	CN¥866.36 Million ≈ $126.78 Million	+17.66pp
2016-12-31	28.82%	CN¥94.00 Million ≈ $13.76 Million	CN¥326.17 Million ≈ $47.73 Million	--

pp = percentage points

About Cansino Biologics Inc

SHG:688185 China Drug Manufacturers - Specialty & Generic

Market Cap

$835.65 Million

CN¥5.71 Billion CNY

Market Cap Rank

#9868 Global

#2630 in China

Share Price

CN¥49.93

Change (1 day)

+0.34%

52-Week Range

CN¥49.41 - CN¥88.48

All Time High

CN¥773.75